Tástálacha maidir le tinneas Afracach eachaí a ndéanann Saotharlann Tagartha an Aontais Eorpaigh um thinneas Afracach eachaí tuairisc orthu:
Tests for African horse sickness described by the European Union Reference Laboratory for African horse sickness:
Tinneas Afracach na gcapall
African horse sickness
tinneas Afracach na gcapall; agus
African horse sickness; and
Víreas thinneas Afracach na gcapall.
African horse sickness virus.
1.Víreas thinneas Afracach na gcapall.
1.African horse sickness virus;
Víreas an tinnis Afracaigh eachaí;
African horse sickness virus;
30 lá (40 lá ó limistéir riosca maidir le tinneas Afracach eachaí)
30 days (40 days from African horse sickness risk areas)
30 lá (40 lá ó limistéir riosca maidir le tinneas Afracach eachaí)”;
30 days (40 days from African horse sickness risk areas)’
Víreas an tinnis Afracaigh eachaí;
African horse sickness virus;
Víreas an tinnis Afracaigh eachaí;
African horse sickness virus;
Ceanglais shonracha maidir le tinneas Afracach eachaí
Specific requirements for African horse sickness
Iarscríbhinn XI maidir le vacsaíniú in aghaidh an tinnis Afracaigh eachaí (AHS).
Annex XI on vaccination against African horse sickness (AHS).
An tinneas Afracach eachaí (AHS)
African horse sickness (AHS)
Víreas an tinnis Afracaigh eachaí;
African horse sickness virus;
tá fianaise dhoiciméadach ann gur vacsaíníodh na hainmhithe in aghaidh tinneas Afracach na gcapall trí bhíthin cúrsa príomhúil iomlán agus gur athvacsaíníodh iad i gcomhréir le moltaí an mhonaróra, le vacsaín cheadúnaithe in aghaidh gach séiritíopa de víreas thinneas Afracach na gcapall atá i láthair sa daonra foinseach 40 lá ar a laghad roimh theacht isteach sna bunaíochtaí atá cosanta ar veicteoirí, agus coimeádadh na hainmhithe ar leithlis i mbunaíochtaí atá cosanta ar veicteoirí ar feadh tréimhse 40 lá ar a laghad roimh an dáta seolta chuig an Aontas,
there is documented evidence that the animals have been vaccinated against African horse sickness with a complete primary course, and revaccinated according to the manufacturer’s recommendations, with a licensed vaccine against all serotypes of the African horse sickness virus present in the source population at least 40 days prior to entry into the vector-protected establishments, and the animals were kept in isolation in vector-protected establishments for a period of at least 40 days prior to the date of dispatch to the Union;
Treoir 92/35/CEE ón gComhairle an 29 Aibreáin 1992 lena leagtar síos rialacha agus bearta rialaithe le tinneas Afracach na gcapall a chomhrac (IO L 157, 10.6.1992, lch. 19).
Council Directive 92/35/EEC of 29 April 1992 laying down control rules and measures to combat African horse sickness (OJ L 157, 10.6.1992, p. 19).
30 lá (40 lá ó limistéir riosca maidir le tinneas Afracach eachaí) nó ón uair a rugadh iad, más rud é gur óige ná 30 lá d’aois (40 lá) atá na hainmhithe, nó óna dteacht isteach ón Aontas
30 days (40 days from African horse sickness risk areas) or since birth, if the animals are less than 30 days (40 days) of age, or since entry from the Union
Le Cinneadh 2008/698/CE rinneadh foráil freisin maidir le réigiúnú na hAfraice Theas, ina luadh gur limistéar saor ó thinneas Afracach eachaí é limistéar uirbeach Cape Town.
Decision 2008/698/EC also provided for the regionalisation of South Africa, indicating the Metropolitan area of Cape Town as an African horse sickness-free area.
Treoir 92/36/CEE ón gComhairle an 29 Aibreán 1992 lena leasaítear, i ndáil le tinneas Afracach na gcapall, Treoir 90/426/CEE maidir le coinníollacha sláinte ainmhithe a rialaíonn gluaiseacht agus allmhairiú equidae ó thríú tíortha (IO L 157, 10.6.1992, lch. 28-29).
Council Directive 92/36/EEC of 29 April 1992 amending, with regard to African horse sickness, Directive 90/426/EEC on animal health conditions governing the movement and import from third countries of equidae (OJ L 157, 10.6.1992, p. 28).
30 lá (40 lá ó limistéir riosca maidir le tinneas Afracach eachaí) nó ón uair a rugadh iad, más rud é gur óige ná 30 lá d’aois (40 lá) atá na hainmhithe, nó óna dteacht isteach ón Aontas nó ó thríú tíortha liostaithe áirithe
30 days (40 days from African horse sickness risk areas) or since birth, if the animals are less than 30 days (40 days) of age, or since entry from the Union or certain listed third countries
Tástálacha ar fhothach, surra, galar cúplála eachaí, ainéime thógálach eachaí agus einceifealaimiailíteas eachaí Veiniséalach a ndéanann Saotharlann Tagartha an Aontais Eorpaigh um Ghalair Eachaí seachas tinneas Afracach eachaí tuairisc orthu: https://sitesv2.anses.fr/en/minisite/equine-diseases/sop
Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine-diseases/sop
Ina theannta sin, chun críoch na gceanglas sonrach le haghaidh each-ainmhithe a mhéid a bhaineann le tinneas Afracach eachaí agus einceifealaimiailíteas eachaí Veiniséalach a leagtar amach in Iarscríbhinn XI, pointí 2.1 agus 2.2, a ghabhann le Rialachán Tarmligthe (AE) 2020/692, is gá sainmhíniú ar “bunaíocht atá cosanta ar veicteoirí” a leagan amach in Airteagal 2 den Rialachán Tarmligthe sin.
In addition, for the purpose of the specific requirements for equine animals as regards African horse sickness and Venezuelan equine encephalomyelitis set out in Annex XI, points 2.1 and 2.2, to Delegated Regulation (EU) 2020/692, it is necessary to lay down a definition of a ‘vector-protected establishment’ in Article 2 of that Delegated Regulation.
Dá bhrí sin, ba cheart don sainmhíniú ar “bunaíocht veicteoir-chosanta” in Airteagal 2 de Rialachán Tarmligthe (AE) 2020/692, chun críoch thinneas Afracach na gcapall agus Einceifilimiailíteas eachaí Veiniséalach, a bheith comhsheasmhach leis an sainmhíniú ar “bunaíocht atá cosanta ar veicteoirí” in Airteagal 2 de Rialachán Tarmligthe (AE) 2020/689.
Therefore, the definition of a ‘vector-protected establishment’ in Article 2 of Delegated Regulation (EU) 2020/692, for the purpose of African horse sickness and Venezuelan equine encephalomyelitis, should be consistent with the definition of the ‘vector-protected establishment’ in Article 2 of Delegated Regulation (EU) 2020/689.
In Iarscríbhinn XI, pointe 2.1 a ghabhann le Rialachán Tarmligthe (AE) 2020/692, leagtar síos na ceanglais shonracha maidir le tinneas Afracach eachaí atá le comhlíonadh ag each-ainmhithe atá ag teacht isteach san Aontas ó thríú tíortha nó críocha, nó criosanna de thríú tír nó de chríoch, a shanntar do ghrúpa sláintíochta E nó F.
Annex XI, point 2.1, to Delegated Regulation (EU) 2020/692 lays down specific requirements for African horse sickness to be fulfilled by equine animals entering the Union from third countries or territories, or zones thereof, assigned to a sanitary group E or F.
coimeádadh na hainmhithe ar leithlis i mbunaíochtaí atá cosanta ar veicteoirí ar feadh tréimhse 30 lá ar a laghad roimh an dáta seolta chuig an Aontas agus cuireadh tástáil shéireolaíoch agus sainaitheanta oibreáin orthu i leith tinneas Afracach na gcapall, ar tástáil í lenar ghabh toradh diúltach i ngach cás agus a rinneadh ar shampla fola a tógadh tráth nach giorra ná 28 lá tar éis an t-ainmhí a thabhairt isteach sna bunaíochtaí atá cosanta ar veicteoirí agus laistigh de thréimhse 10 lá roimh an dáta seolta chuig an Aontas,
the animals were kept in isolation in vector-protected establishments for a period of at least 30 days prior to the date of dispatch to the Union and a serological and an agent identification test for African horse sickness were carried out with negative result in each case on a blood sample taken not less than 28 days after the date of introduction into the vector-protected establishments and within a period of 10 days prior to the date of dispatch to the Union;
coimeádadh na hainmhithe ar leithlis i mbunaíochtaí atá cosanta ar veicteoirí ar feadh tréimhse 40 lá ar a laghad roimh an dáta seolta chuig an Aontas agus cuireadh tástálacha séireolaíocha orthu chun antashubstaintí in aghaidh víreas thinneas Afracach na gcapall a bhrath, ar tástáil í nár ghabh aon mhéadú suntasach ar thítear antasubstainte léi agus a rinneadh ar shamplaí fola a tógadh ar dhá ócáid a raibh eatramh nach giorra ná 21 lá eatarthu agus ar bailíodh an chéad sampla acu 7 lá ar a laghad tar éis an dáta a tugadh na hainmhithe isteach sna bunaíochtaí atá cosanta ar veicteoirí,
the animals were kept in isolation in vector-protected establishments for a period of at least 40 days prior to the date of dispatch to the Union and serological tests to detect antibodies against African horse sickness virus were carried out with no significant increase in antibody titre on blood samples collected on two occasions, with an interval of not less than 21 days, the first sample being collected at least 7 days after the date of introduction into the vector-protected establishments;
coimeádadh na hainmhithe ar leithlis i mbunaíochtaí atá cosanta ar veicteoirí ar feadh tréimhse 14 lá ar a laghad roimh an dáta seolta chuig an Aontas agus cuireadh tástáil sainaitheantais oibreáin orthu i leith víreas thinneas Afracach na gcapall, ar tástáil í lenar ghabh toradh diúltach agus a rinneadh ar shampla fola a tógadh tráth nach giorra ná 14 lá tar éis an t-ainmhí a thabhairt isteach sna bunaíochtaí atá cosanta ar veicteoirí agus nach faide ná 72 uair an chloig roimh an am seolta chuig an Aontas, agus cruthúnas faighte, mar thoradh ar shíor-fhaireachán a dhéanamh ar an gcosaint ar veicteoirí, nach ann do veicteoirí feithide laistigh de na bunaíochtaí atá cosanta ar veicteoirí,
the animals were kept in isolation in vector-protected establishments for a period of at least 14 days prior to the date of dispatch to the Union and an agent identification test for African horse sickness virus was carried out with negative result on a blood sample taken not less than 14 days after the date of introduction into the vector-protected establishments and not more than 72 hours before the time of dispatch to the Union, and constant monitoring of the vector protection has proven absence of insect vectors inside the vector-protected establishments;
coimeádadh na hainmhithe ar leithlis i mbunaíochtaí atá cosanta ar veicteoirí ar feadh tréimhse 30 lá ar a laghad roimh an dáta seolta chuig an Aontas agus cuireadh tástáil shéireolaíoch orthu i leith antashubstaintí in aghaidh víreas thinneas Afracach na gcapall a bhrath, ar tástáil í a rinne an tsaotharlann chéanna, an lá céanna, ar shampla fola a tógadh i rith na tréimhse leithlise i mbunaíochtaí atá cosanta ar veicteoirí ar dhá ócáid a raibh eatramh idir 21 lá agus 30 lá ann eatarthu,
the animals were kept in isolation in vector-protected establishments for a period of at least 30 days prior to the date of dispatch to the Union and underwent a serological test for the detection of antibodies against the African horse sickness virus, carried out by the same laboratory, on the same day, on blood samples taken during the isolation period in vector-protected establishments on two occasions with an interval of between 21 and 30 days.
Ní mór, maidir leis an dara ceann acu sin, gur tógadh é laistigh de thréimhse 10 lá ón dáta seolta chuig an Aontas, agus ní mór torthaí diúltacha a bheith ann i ngach cás nó ní mór toradh diúltach a bheith ann i dtástáil sainaitheanta oibreáin i leith víreas thinneas Afracach na gcapall a mhéid a bhaineann leis an dara sampla.”,
The second of these must have been taken within a period of 10 days prior to the date of dispatch to the Union, with negative results in each case or with a negative result in an agent identification test for African horse sickness virus on the second sample.’;
Ina theannta sin, pointe II.3.2 de dheimhniú caighdeánach ‘EQUI-X’ a bhaineann le ceanglais maidir le sláinte ainmhithe i dtaca leis an tinneas Afracach eachaí agus eachainmhithe a leithlisiú i mbunaíochtaí atá cosanta ar veicteoirí atá lonnaithe i dtríú tíortha atá sannta do Ghrúpa Sláinteachais F, ba cheart iad a ailíniú le forálacha phointe 2.1 d’Iarscríbhinn XI a ghabhann le Rialachán (AE) 2020/692.
Additionally, point II.3.2 of model ‘EQUI-X’ concerning animal health requirements related to African horse sickness and isolation of equine animals in vector-protected establishments situated in third countries assigned to Sanitary Group F should be aligned with provisions of point 2.1 of Annex XI to Delegated Regulation (EU) 2020/692.